Actively Recruiting
To Identify Potential New Urine Marker Panel for Cancer Screening
Led by Chinese University of Hong Kong · Updated on 2025-05-06
2500
Participants Needed
1
Research Sites
270 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore the use of urinary polyamine for the diagnosis of common cancers.
CONDITIONS
Official Title
To Identify Potential New Urine Marker Panel for Cancer Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with age > 18 years old.
- For cancer patients, a histological diagnosis of cancer is available.
- For normal control, there is no diagnosis of cancer in the medical record.
You will not qualify if you...
- Patient with recent urinary tract infection within 6 weeks prior to urine collection.
- Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection.
- Patient refused or unable to provide consent for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Shatin, Hong Kong
Actively Recruiting
Research Team
C
Chi Fai Ng, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here